Psychotropics Marketing And Advertising Profile
Key Indicators
- Authorised Capital ₹ 8.35 Cr
as on 09-01-2025
- Paid Up Capital ₹ 8.33 Cr
as on 09-01-2025
- Company Age 30 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.45 Cr
as on 09-01-2025
- Revenue -69.68%
(FY 2022)
- Profit -89.41%
(FY 2022)
- Ebitda -70.45%
(FY 2022)
- Net Worth 2.28%
(FY 2022)
- Total Assets -6.62%
(FY 2022)
About Psychotropics Marketing And Advertising
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.35 Cr and a paid-up capital of Rs 8.33 Cr.
The company has closed loans amounting to ₹2.45 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Navdeep Chawla and Amita Chawla serve as directors at the Company.
- CIN/LLPIN
U73100HR1994PTC080943
- Company No.
080943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 1994
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Psychotropics Marketing And Advertising?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navdeep Chawla  | Director | 28-Dec-1994 | Current |
| Amita Chawla | Director | 01-Oct-2007 | Current |
Financial Performance of Psychotropics Marketing And Advertising.
Psychotropics Marketing And Advertising Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 69.68% decrease. The company also saw a substantial fall in profitability, with a 89.41% decrease in profit. The company's net worth moved up by a moderate rise of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Psychotropics Marketing And Advertising?
In 2020, Psychotropics Marketing And Advertising had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pil Pharmaceuticals LimitedActive 17 years 7 monthsNavdeep Chawla and Amita Chawla are mutual person
Psychotropics India LimitedActive 38 years 6 monthsNavdeep Chawla and Amita Chawla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 19 Feb 2003 | ₹1.22 Cr | Satisfied |
Allahabad Bank Creation Date: 19 Feb 2003 | ₹2.80 M | Satisfied |
Allahabad Bank Creation Date: 27 Dec 1999 | ₹7.50 M | Satisfied |
How Many Employees Work at Psychotropics Marketing And Advertising?
Unlock and access historical data on people associated with Psychotropics Marketing And Advertising, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psychotropics Marketing And Advertising, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psychotropics Marketing And Advertising's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
